SAFETY AND TOXICITY PROFILE OF SOME METALLIC PREPARATIONS OF AYURVEDA by Prajapati, P.K. et al.
Ancient Science of Life       Vol: XXV(3&4) January, February, March, April, May, June 2006 Pages 57 - 63
 
SAFETY AND TOXICITY PROFILE OF SOME METALLIC 
PREPARATIONS OF AYURVEDA 
 
         P. K. PRAJAPATI, PRASANTA KUMAR SARKAR, SUHAS V. NAYAK,  
         RENUKA D. JOSHI, B. RAVISHANKAR. 
Department of Rasashastra and Bhaishajya Kalpana Including Drug Research, 
Pharmacology Laboratory. 
Institute for Post Graduate Teaching and Research in Ayurveda, 
Gujarat Ayurved University, Jamnagar- 361008 
Received : 11-11-2005                  Accepted : 22-12-2005 
 
ABSTRACT: 
 
Metals and minerals are used profusely in practice of Ayurveda after proper incineration by the 
name of Bhasma. Some metals and minerals have the potency to produce toxic effects in human 
being.  In  this  paper  safety  and  toxicity profiles  of Tamra  Bhasma  (incinerated  copper,  Cu), 
Lauha Bhasma (incinerated  iron, Fe), and  Yashada Bhasma (incinerated  Zinc, Zn) has been 
presented, which reveal no serious deleterious effects on body function as a whole. 
 
Key Words: Toxicity, Metal, Ayurveda, Tamra (Copper), Lauha (Iron), Yashada (Zinc). 
 
INTRODUCTION: 
 
The Ayurvedic system of medicine has been 
in  vogue  since  the  Vedic  period  or  even 
earlier. In principle this system advocates a 
holistic approach to the human health care 
i.e. a balance between the physical, mental 
and spiritual functions of the human body. It 
is the sum total of the knowledge, skills and 
practices based on the theories, beliefs and 
experiences.  This  system  of  medicine 
involves  the  use  of  plant  parts,  animal 
products, minerals and metals. 
 
Long historical use of practices of Ayurvedic 
system  of  medicine,  including  experience 
passed on from generation to generation, has 
demonstrated the safety and efficacy of this 
system. However, so many research works 
have been carried out to provide additional 
evidence  of its  safety  and  efficacy  profile. 
But  the  quantity  and  quality  of  the  safety 
and  efficacy  data  on Ayurvedic  medicines 
are  far  from sufficient  to  meet  the  criteria 
needed to support its use worldwide. 
 
Institute  for  Post  Graduate  Teaching  and 
Research  in Ayurveda  of  Gujarat Ayurved 
University is the pioneer institute in the field 
of  research  on  Ayurvedic  medicines.  This 
institute  has  given  enormous  efforts  since 
last  fifty  years  in  research  in  Ayurvedic 
medicines with special emphasis on metallic 
and  mineral  preparations.  In  this  present 
paper,  the  studies  on  safety  and  toxicity 
profile  of  Tamra  Bhasma  (incinerated 
copper),  Lauha  Bhasma  (incinerated  iron), 
and  Yashada  Bhasma  (incinerated  zinc) 
have been enlightened. 
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RECENT PUBLICATION REGARDING 
REACTIVITY OF SOME AYURVEDIC 
PREPARATIONS: 
 
An article entitled “Ayurveda – The Death 
Metal  Soup”  was  published  in  ‘Outlook 
Express’  magazine  highlighting  effects  of 
some Ayurvedic preparations containing lead 
(Pb)  and  arsenic  (As).  This  article  also 
mentioned  the  permissible  limit  of  some 
heavy  metals  and  enlisted  some  heavy 
metals containing Ayurvedic preparations. 
 
In ‘Energy Monitor Journal’, an article had 
been  published  entitled  “Scenario  of  ‘Pb 
pollution and children’ in Mumbai: Current 
air  quality  standard  vindicated”  presented 
current  situation  of  lead  (Pb)  pollution  in 
Mumbai  and  cases  of  lead  (Pb)  poisoning 
due  to  ingestion  of  lead  (Pb)  containing 
Ayurvedic preparations
1. 
 
The  latest  exclusive  article,  which  had 
shaken the Ayurvedic world, was published 
in Journal of American Medical Association 
entitled “Heavy metal content of Ayurvedic 
herbal medicinal products”. This article was 
mentioned  some  Ayurvedic  formulations 
containing  heavy  metals  and  permissible 
limits of these in human being and presented 
some case reports on adverse effect of some 
Ayurvedic  herbal  formulations  containing 
heavy metals
2. 
 
ANCIENT  CONCEPT  REGARDING 
METAL PHARMACOLOGY: 
 
Therapeutic  effectiveness  of  the  Ayurvedic 
drugs  have  been  established  and  well 
documented  by  the  great  Acharyas  in  the 
form of classics attributed to them. However 
lot of changes have occurred in our living 
milieu  since  the  time  these  classics  were 
written and impact of these changes on the 
therapeutic  efficacy  of  the  preparations 
formulated has not been ascertained. Further 
the art of preparing the preparations requires 
certain  amount  of  expertise  and  no  much 
information  is  available  about  the  likely 
impact  of  improper  preparation  on  the 
expression  of  biological  activity  including 
possibility  of  production  of  undesirable 
effects.  
 
Gold  preparations  are  generally  used  in 
general  debility,  poisoning,  etc.  and  as 
immunomodulator
3.  But  improperly 
prepared Swarna Bhasma (incinerated gold) 
may causes emaciation, many other diseases 
even  death
4.  Silver  preparations  are 
generally  prescribed  in  epilepsy, 
spleenomagaly,  etc.  and  as  nervous  tonic
5. 
But  defectively  prepared  Rajat  Bhasma 
(incinerated  silver)  may  leads  to  fever, 
constipation,  etc.
6  Tamra  preparations  are 
used  systematically  in  abdominal  pain, 
respiratory distress, obesity, skin disorders, 
etc.
7  And  vomiting,  dyspepsia,  excessive 
perspiration,  fainting  attack,  skin  disorders 
may  occur,  if  improperly  prepared  Tamra 
Bhasma (incinerated copper) is taken.
8 Like 
wise the adverse effect of other metals used 
therapeutically  in  Ayurveda  like  Parada 
(mercury), Lauha (iron), Vanga (tin), Naga 
(lead),  Yashada (zinc)  are also  describe  in 
management of their adverse effects are also 
mentioned (presented in Table 1). 
 
PREPARATION  OF  DHATU  BHASMA 
(INCINERATED METAL): 
 
Ayurvedic  system  of  medicine  is  the  only 
one out of all traditional medicine system of 
various  civilizations,  where  importance  of 
metals  for  curing  ailments  was  first 
recognized. Metallic preparations are mainly 
termed  as  ‘Bhasma’  and  obtained  by 
repeated  incineration  of  metal  with  herbal 
extracts or juice. 
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For  this  purpose,  after  procurement  of 
metals, these are made into coarse powder 
by hammering. Then these are subjected to 
Shodhana  (purification)  procedure 
according  to  traditional  Ayurvedic 
references. For this, the metals are heated to 
red hot or melted and quenched in particular 
liquid media for specified times. Then these 
Shodhita  metals  are  subjected  to  Marana 
(incineration). The Shodhita metals are then 
mixed  with  specific  drugs  for  incineration 
(Maraka  Dravyas)  and  are  levigated 
(Bhavana)  by  particular  liquid  media  for 
specified  time.  Chakrikas  (pellets)  are 
prepared  from  levigated  doughy  mass  and 
taken into earthen crucibles faced together, 
and the junction is sealed by mud smeared 
clothes.  This  apparatus,  called  as  Sarava 
Samputam  is  subjected  for  heating  in 
traditional  Puta  (heating  grade)  or  electric 
muffle  furnace.  Heating  of  materials 
continue  to  this  apparatus  is  called  as 
Putapaka in parlance of Ayurveda. Burning 
is  continued  for  a  specific  time  limit  and 
when cooled down the apparatus is taken out 
and  open  to  get  the  incinerated  metallic 
powder. These procedures are repeated for 
particular  time  and  finally  the  prepared 
Bhasma (incinerated metal) is collected.      
 
TOXICITY STUDY: 
 
Objective:  
 
To  evaluate  the  acute  and  chronic  toxicity 
profile  of  the  prepared  Bhasmas  (Tamra, 
Lauha  and  Yashada)  (incinerated  copper, 
iron and zinc) on experimental animal. 
 
MATERIALS AND METHODS: 
 
Animal: Charles Foster strain albino rats of 
either sex weighing between 180g to 250g 
were used for these experiments. They were 
obtained from the animal house attached to 
the  pharmacology  laboratory.  They  were 
housed  in  breeding  cases  at  an  ambient 
temperature  with  a  natural  day  and  night 
cycles. The animals had free access of pellet 
feed and tap water. 
 
Drugs: 
 
Tamra  Bhasma:  The  copper  wire  was 
collected  and  subjected  for  Shodhana 
(purification)  according  to  traditional 
Ayurvedic  procedures.  The  purified  metal 
then  mixed  with  drugs  for  incineration 
(Shuddha  Hingula,  purified  cinnabar,  and 
Shuddha  Gandhaka,  purified  sulphur)  and 
levigated  by  lemon  juice,  pellets  were 
prepared  and  subjected  for  heat  treatment 
(Putapaka). These procedures were repeated 
for  6  times,  and  then  prepared  Tamra 
Bhasma was collected and stored. 
 
Lauha Bhasma: The scraps of wrought iron 
were  purified  (Shodhana)  according  to 
traditional  procedures  of  Ayurveda.  The 
purified metal was mixed with 1/12 th part 
of  Shuddha  Hingula  (purified  cinnabar)  as 
drug for incineration and was levigated by 
Kumari  Swarasa  (aloe  gel).  Pellets  were 
prepared  and  subjected  for  heat  treatment 
(Putapaka). These procedures were repeated 
for 7 times. 
 
Yashada  Bhasma:  After  purification 
(Shodhana)  amalgam  of  purified  zinc  was 
prepared by mixing with same part mercury 
(Parada),  then  same  part  of  Shuddha 
Gandhaka (purified sulphur) was mixed and 
triturated. The mixture was subjected to heat 
treatment. These  procedures  were  repeated 
for 8 times. 
 
Drug  and  dose:  Drug  (Tamra  Bhasma, 
Lauha  Bhasma,  Yashada  Bhasma) 
suspensions  were  prepared  by  adding  few 
drops of 5% gum acacia solution in distilled 
water. The  dose  for  experimental  study  of 
the  test  drugs  were  calculated  by 
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extrapolating the human dose to animal dose 
based on body surface area ratio.  
 
Study protocol: 
 
Acute  Toxicity  Study:  Acute  toxicity  of 
Tamra  Bhasma,  Lauha  Bhasma  and 
Yashada  Bhasma  were  evaluated  by 
administering single oral dose of 5 times, 10 
times, 20 times and 40 times more than the 
therapeutic dose of test drug suspensions. 
 
Chronic  Toxicity  Study:  Chronic  toxicity 
of  Tamra  Bhasma,  Lauha  Bhasma  and 
Yashada  Bhasma  were  assessed  by 
administering 5 times more than therapeutic 
equivalent  dose  of  test  drugs  suspension 
through oral route by No. 3 simple rubber 
catheter for 45 days.  
 
RESULTS: 
 
Acute Toxicity Study: The animals of all 
the  test  drug  groups  did  not  manifest  any 
signs of toxicity and no exitus (death) was 
observed  upto  40  times  more  than  the 
therapeutic equivalent dose. From this it can 
be  mentioned  that  the  approximate  LD50 
values are more than 40 times of therapeutic 
equivalent dose. 
 
Chronic Toxicity Study:   
 
Effect of test drug preparations on body 
weight and other ponderal parameters:  
 
The mean body weight of the albino rats in 
different  test  drugs  treatment  groups  were 
recorded before and after drug treatment and 
weight of the vital organs were taken after 
scarification.  The  effect  of  the  test  drugs 
pertaining to the ponderal parameters have 
been presented in Table- 2. Body weight of 
rats  was  increased  in  all  the  test  drugs 
treated groups. It was increased significantly 
(P‹0.05)  in Yashada  Bhasma  treated  group 
and increased marginally in Tamra Bhasma 
and  Lauha  Bhasma  Treated  groups.  No 
apparent  changes  in  weight  of  the  vital 
organs  were  noticed  in  all  the  test  drug 
treated  groups  in  comparison  to  control 
group.  Only  the  weight  of  testes  was 
decreased  significantly  (P‹0.05)  in  Tamra 
Bhasma  treated  group  in  comparison  to 
control  group  and  weight  of  thymus  and 
prostate  were  increased  in  Lauha  Bhasma 
treated group. 
 
Effect  of  test  drug  preparations  on 
haematological parameters:  
 
Post  treated  values  of  the  haematological 
parameters (Hb%, total RBC count, total and 
differential WBC count, etc.) in all the test 
drug  treated  groups  were  estimated 
statistically  and  have  been  presented  in 
Table-  3.  Statistically  non-significant 
changes  were  observed  on  almost  all  the 
parameters  in  the  entire  test  drug  treated 
groups,  except  in  Tamra  Bhasma  treated 
group  haemoglobin  percentage  (Hb%)  was 
increased  significantly  (P‹0.05),  Plateletcrit 
value,  mean  platelet  volume  and  platelet 
distribution  width  were  decreased  highly 
significantly  (P‹0.01)  in  Lauha  Bhasma 
treated  group  and  in  Yashada  Bhasma 
treated  group  mean  platelet  volume  was 
decreased  significantly  (P‹0.05).  All  the 
values  were  assessed  in  comparison  to 
vehicle treated control group.     
 
Effect  of  test  drug  preparations  on 
biochemical parameters:  
 
Biochemical  parameters  (blood  glucose, 
serum urea, serum creatinine, etc.) of rats in 
all  the  test  drug  treated  groups  were 
estimated  statistically  after  completion  of 
treatment and have been presented in Table- 
4.  In  Tamra  Bhasma  treated  group,  serum 
creatinine,  serum  triglyceride  and  serum 
cholesterol  were  decreased  significantly 
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(P‹0.05)  and  blood  glucose  and  serum 
alkaline  Phosphatase  were  increased 
significantly  (P‹0.05).  In  Lauha  Bhasma 
treated  group  only  serum  alkaline 
Phosphatase  and  serum  HDL  cholesterol 
were decreased significantly (P‹0.05) and no 
apparent  changes  was  observed  in  other 
parameters.  In  Yashada  Bhasma  treated 
group,  serum  creatinine  was  decreased 
significantly (P‹0.05) and serum cholesterol 
was increased highly significantly (P‹0.01), 
no  apparent  changes  were  found  in  other 
parameters. All the values were calculated in 
comparison to vehicle treated control group. 
 
Effect  of  test  drug  preparations  on 
histopathology of vital organs: Microscopic 
examination  of  sections  of  vital  organs 
(liver, heart, kidney, brain, etc.) from treated 
groups  was  observed  under  microscope  at 
different  magnifications.  Tamra  Bhasma 
caused  mild  to  moderate  degenerative 
changes  in most  of the vital  organs  (liver, 
spleen  kidney,  etc.).  In  Lauha  Bhasma 
treated  group  moderate  fatty  degenerative 
changes  in  liver  was  observed,  other  vital 
organs  exhibits  almost  normal 
cytoarchitecture. Yashada Bhasma enhanced 
increase  in  the  epithelial  proliferation  in 
seminal  vesicle  and  ventral  prostate  and  it 
has  the  potential  of  affecting  kidney 
function. 
 
DISCUSSION: 
 
The  people  become  so  much  health 
conscious,  so  naturally  the  quality 
consciousness of the drug is also increased. 
Before  taking  the  medicine  they  want  to 
assure  about  the  safety  and  purity  of  the 
same,  the  published  articles  make  them 
more  cautious.  And  these  phenomenons 
indirectly indicate the need of toxicity study 
of the Ayurvedic medicines. 
 
Now  a  days  it  is  essential  for  all  the 
Ayurvedic  practitioners  to  know  the 
particulars  of  toxicity  profile  of  the 
Ayurvedic medicines, which they intend to 
use in clinical practice. This is very essential 
especially  for  the  medicines  containing 
metals,  minerals  and  organic  poisonous 
substances.  
 
The toxicity of heavy metals is attributed to 
their  ability  to  form  complexes  with 
important  biological  radicals  like  the 
sulfhydryl,  the  hydroxyl,  the  carboxyl,  the 
amino  and  the  imidazole.  Inhibition  of 
various enzymes leads to the toxic effects. 
Attempts were, therefore, made to develop 
organic  compounds  which  would  have  a 
high affinity for the metallic ions. Such drug 
would  combine  with  the  metallic  ions  to 
produce  relatively  non-toxic  substances.
9 
The  process  by  which  these  organic 
materials impregnated into the metal ions is 
called as Bhavana (levigation).  
Metals  and  minerals  that  are  transformed 
into  drug  must  have  excellent  therapeutic 
efficacy  and  must  be  safe.  Unfortunately 
some metals and minerals have the potential 
to  produce  adverse  effects.  Therefore, 
during  transmutation  of  the  metals  and 
minerals to drugs, it is essential to evaluate 
the margin of safety between the dose level 
that produces the therapeutic effects and that 
produces  the  adverse  effects.  That  is  to 
provide benefit to risk assessment. Animal 
experimentation  is  the  only  way  through 
which this assessment can be made. 
 
At  higher  dose  level  Tamra  Bhasma  has 
tendency  of  producing  toxicity.  The 
observed  toxic  effects  were  moderate  in 
intensity. There is possibility that these toxic 
effects  may  not  occur  at  therapeutic 
equivalent dose, which is five fold smaller 
than  the  administered  dose.  This  aspect 
needs to be considered. However, it is to be 
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always kept in mind that higher doses have 
definite predilection of producing toxicity.
10  
 
In Lauha Bhasma treated group, no serious 
toxicity was found. Only mild impairment in 
the  hepatic  functions  and  hepatic 
cytoarchitecture  was  observed.  So  Lauha 
Bhasma should be considered as safe drug 
and has a wide range of safety.
11 Yashada 
Bhasma has no serious deleterious effect on 
body  functions  as  a  whole,  the  epithelial 
proliferation  may  be  indicative  of 
androgenic  activity  and  may  not  be 
considered as pathological changes and the 
changes in kidney function are of moderate 
intensity, they are likely to be reversible. It 
has  moderate  cytoprotective  activity  by 
promoting  the  formation  of  anti-stress 
proteins,  by  promoting  the  turnover  of 
epithelial  tissues  in  different  organs,  by 
inhibiting  lipid  peroxidation  and  DNA 
fragmentation in target tissues.
12 
 
All  the  Bhasma  (incinerated  metallic  ash) 
preparations are the cocktail of many other 
trace  elements. Presence  of  these  elements 
from  conceptual  point  of  view  should  be 
important  for  the  expression  of  biological 
activity, may be beneficial or toxic. 
 
CONCLUSION: 
 
Analysis  of  these  data  of  toxicity  study 
reveals these Bhasma preparations have no 
serious deleterious effect on body function 
as  a  whole.  However,  caution  should  be 
taken while preparing these preparations and 
calculating  the  dose  and  duration  during 
clinical practice.    
         
 
 TABLE- 1: ANCIENT CONCEPT REGARDING METAL PHARMACOLOGY: 
 
Metallic 
Preparations 
Indications  Adverse Effects  Management 
Parada 
(Mercury, Hg) 
In all the diseases with 
specific Anupana 
(adjuvant). 
Murcha (fainting), 
Chhardi (vomiting), 
Atisara (diarrhoea), 
Shwasa (dyspnoea), etc. 
even death. 
Kanji (sour gruel) 
+ Sarjika Kshara 
(KNO3) + 
cow’s urine + rock salt
Swarna   
(Gold, Au) 
Kshaya (emaciation), 
Shwasa (dyspnoea), Kasa 
(cough), Pandu (anaemia), 
Hridya (cardiac tonic), 
Rasayana 
(immunomodulator), etc.  
Decrease Oja and Bala 
(defense mechanism), 
creates many other 
diseases even death. 
Haritaki (Terminalia 
chebula) powder + Sita 
(sugar candy)       
Rajata  
(Silver, Ag) 
Madataya (alcohol 
poisoning), Kshaya 
(emaciation), Plihodara 
(spleenomagaly), Apasmara
(epilepsy), etc.    
Jwara (fever), Vivandha
(constipation), 
Angasada (body ache), 
etc. 
Honey + sugar 
Tamra 
(Copper, Cu) 
Pandu (anaemia),Krimi 
(warm infestation),Sthaulya 
(obesity), Kustha (skin 
disorders) etc. 
Vamana (vomiting), 
Shula (spasmodic pain), 
Kustha (skin disorders), 
etc. evan death. 
Dhanyaka (Corindrum 
sativum) + sugar or 
Munibrihi (Sesbania 
grandiflora) + sugar 
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Lauha  
(Iron, Fe) 
Pandu (anaemia), Shotha 
(oedema), Rajyakshma 
(tuberculosis), Kustha (skin 
disorders), Rasayana 
(immunomodulator), etc. 
Hritpida (angina), 
Ashmari (urolethiasis), 
Apasmara (epilepsy), 
Sotha (oedema), Shula 
(abdominal colic), etc. 
Vidanga (Embelia ribes)
+ Juice of Agasta 
(Sesbania grandiflora), 
or Aragvadha Phala 
Majja (Cassia fistula). 
Vanga  
(Tin, Sn) 
Krimi (warm infestation), 
Vamana (vomiting), Kasa 
(cough), Shwasa 
(dyspnoea), Pandu 
(anaemia), Prameha 
(diabetes mellitus), etc. 
Prameha (diabetes 
mellitus), Kasa (cough), 
Shwasa (dyspnoea), 
Pandu (anaemia), 
Shotha (oedema),etc. 
Mesashringi (Gymnema
sylvestre) powder + Sita
(sugar candy) 
Naga        
(Lead, Pb) 
Prameha( diabetes mellitus, 
Arsha (piles), Varna ( 
ulcer), Pradara 
(leucorrhoea), Sukrakshaya 
( oligospesrmia),etc. 
Murcha (fainting ), 
Prameha(diabetes 
mellitus ), Pakshavadha 
(paralysis), Shotha 
(oedema), etc. 
Swarna Bhasma + 
Haritaki (Terminalia 
chebula)+ sugar 
Yasada  
(Zinc, Zn) 
Prameha (diabetes 
mellitus), Pandu (anaemia), 
Shwasa (dyspnoea), 
Netraroga (eye diseases), 
Vrana (ulcer), etc. 
Prameha (diabetes 
mellitus), Kshaya 
(emaciation), Vamana 
(vomiting), Kustha (skin 
disorders), etc. 
Vala (Sida cordifolia) 
powder + Haritaki 
(Terminalia chebula) 
powder + Sita (sugar 
candy). 
 
TABLE- 2: EFFECT OF BHASMAS ON PONDERAL PARAMETERS: 
 
Parameter   Tamra Bhasma  Lauha Bhasma  Yashada Bhasma 
Body Weight    NE  NSI  SI 
Liver   NE  NSD  NSI 
Thymus   NSD  SI  NSD 
Spleen   NSI  NSD  NSI 
Kidney   NE  NSI  NSD 
Heart   NE  NSD  NSD 
Testes   SD  NSI  NSD 
Seminal vesicles    NE  NSI  NSD 
Prostate   NSI  SI  NSD 
Uterus   NE  NSD  NSI 
 
NE: No effect; SD: Significant decrease; SI: Significant increase; NSI: Non-significant increase; 
NSD: Non-significant decrease. 
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TABLE- 3: EFFECT OF BHASMAS ON BIOCHEMICAL PARAMETERS: 
 
Parameter  Tamra Bhasma  Lauha Bhasma  Yashada Bhasma 
Blood Glucose  SI  NSI  NSI 
Serum Cholesterol  SD  NSD  NE 
Serum Urea  NE  NSD  NSI 
Serum Creatinine  SD  NSI  SD 
Serum Triglyceride  SD  NSI  NSI 
Serum Bilirubin  NE  NSD  NSD 
S. G. O. T.  NE  NSD  NE 
Serum Alkaline 
Phosphatase 
SI  SD  NE 
Serum Total Protein  NE  NSI  NE 
S. G. P. T.  NE  NSI  NSI 
 
 
TABLE- 4: EFFECT OF BHASMAS ON HAEMATOLOGICAL PARAMETERS: 
 
Parameter  Tamra Bhasma  Lauha Bhasma  Yashada Bhasma 
Total RBC count  NE  NSI  NE 
Haemoglobin %  SI  NSI  NSD 
Haematocrit  NE  NSI  NE 
RDW  NE  NSI  NE 
MCV  NE  NSD  NE 
MCH NE  NSD  NE 
MCHC  NE  NSD  NE 
Total WBC count  NSD  NSI  NSI 
Polymorph %  NSD  NSI  NSI 
Lymphocyte %  NSI  NSD  NSI 
Eosinophil %  NSD  NSD  NSD 
Platelet count  NE  NSD  NSD 
Plateletcrit  NE  NSD  NSD 
PDW  NE  NSD  NE 
MPV  NE  NSD  SD 
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